VANCOUVER, BC / December 18, 2019 / AREV Brands International Ltd. (“AREV” or the “Company”) (OTCQB: AREVF) (CSE – AREV) (the “Company” or “AREV”) is pleased to announce the appointment of Mr. Michael Frank Phillet as Director and Interim Chief Financial Officer (“CFO”) to the Company and the resignation of Mr. Leo Ford from the Board of Directors of the Company.
Mr. Phillet holds a BA, and a CA and CPA designation. He has been in public practice for 40 years. Michael Frank Phillet is on the board of First West Properties Ltd. and APA Bioceuticals, Inc. and is a Partner at Phillet & Mclennan Chartered Accountants.
In his past career Mr. Phillet was Chairman & Chief Executive Officer at Immunal Sciences, Chief Financial Officer at Dev Studios International, Inc. and CFO of CV Technologies Inc , a publicly traded company (producer of Cold FX and related products). He was a director of Mosaic Capital Corp. a publicly traded company. Mr. Phillet has launched and currently manages the affairs of several private companies involved in such diverse areas as education, sports, music, production of supplements for athlete animals, and other ventures.
The Company would like to thank Mr. Ford for his efforts and wishes him well in future endeavours.
For further information, contact Mike Withrow, mike@AREVBrands.com 778-379-8551.
On behalf of the Board,
CEO & Director
About AREV Brands International Ltd.
AREV Brands International Ltd. (“AREV”) produces and delivers functional compounds and ingredients derived from verified genetics ran through its world-class extraction systems. AREV is revolutionizing the current delivery method of terpenes, cannabinoids and flavonoids. These premium ingredients and formulations are used in products targeted for sale in the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV innovates through extraction to produce extracts from specific selected plant and exude from trees that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws. This press release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks various risk factors discussed in the Company’s Management’s Discussion and Analysis under the Company’s profile on www.sedar.com.